Stereotactic body radiotherapy: A critical review for nonradiation oncologists
暂无分享,去创建一个
F. Yin | J. Kirkpatrick | C. Kelsey | P. Patel | A. Cabrera | M. Palta | J. Salama | Bradford A Perez | Jason Lee
[1] R. Weichselbaum,et al. Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma , 2013, American journal of clinical oncology.
[2] RobertI Miller,et al. American Society for Radiation Oncology (ASTRO) 2012 Workforce Study: the radiation oncologists' and residents' perspectives. , 2013, International journal of radiation oncology, biology, physics.
[3] D. Sher,et al. Cost‐effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non–small cell lung cancer , 2013, Cancer.
[4] F. Yin,et al. Radiotherapy and radiosurgery for tumors of the central nervous system. , 2013, Surgical oncology clinics of North America.
[5] T. Showalter,et al. Pushing the limits of radiation therapy for prostate cancer: where do we go next? , 2013, Seminars in oncology.
[6] William Small,et al. Perez & Brady's Principles and Practice of Radiation Oncology , 2013 .
[7] Zahra Kassam,et al. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] C. Stief,et al. Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer. , 2013, Urologic oncology.
[9] S. T. Astner,et al. Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapy , 2013, Strahlentherapie und Onkologie.
[10] D. Schaal,et al. Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Cost-Effectiveness Results , 2013, Front. Oncol..
[11] P. Bondiau,et al. Phase 1 clinical trial of stereotactic body radiation therapy concomitant with neoadjuvant chemotherapy for breast cancer. , 2013, International journal of radiation oncology, biology, physics.
[12] S. Demaria,et al. Combining radiotherapy and cancer immunotherapy: a paradigm shift. , 2013, Journal of the National Cancer Institute.
[13] Oleksiy Karpenko,et al. Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs , 2012, PloS one.
[14] P. Lambin,et al. Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450) , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[15] P. Okunieff,et al. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. , 2012, International journal of radiation oncology, biology, physics.
[16] S. Perkins,et al. Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma , 2012, Cancer.
[17] Y. Lotan,et al. Cost-effectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: an emerging initial radiation treatment option for organ-confined prostate cancer. , 2012, Journal of oncology practice.
[18] Jan-Jakob Sonke,et al. Quality assurance for image-guided radiation therapy utilizing CT-based technologies: a report of the AAPM TG-179. , 2012, Medical physics.
[19] P. Brown,et al. Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. , 2012, The Lancet. Oncology.
[20] Aaron Ward,et al. Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literature. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] Michael Lock,et al. Radiotherapy for liver metastases: a review of evidence. , 2012, International journal of radiation oncology, biology, physics.
[22] R. Orecchia,et al. Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer. , 2012, International journal of radiation oncology, biology, physics.
[23] R. Weichselbaum,et al. Hypofractionated Image-Guided Radiation Therapy for Patients with Limited Volume Metastatic Non-small Cell Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[24] Timothy D. Solberg,et al. Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary , 2012, Practical radiation oncology.
[25] P. Parikh,et al. Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer. , 2011, International journal of radiation oncology, biology, physics.
[26] Cynthia S. Johnson,et al. Stereotactic body radiotherapy for primary hepatocellular carcinoma. , 2011, International journal of radiation oncology, biology, physics.
[27] J. Ledermann,et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[28] Joe Y. Chang,et al. Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy. , 2011, International journal of radiation oncology, biology, physics.
[29] Thierry Gevaert,et al. Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial. , 2011, International journal of radiation oncology, biology, physics.
[30] A. Garg,et al. Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy , 2011, Cancer.
[31] J. Bradley,et al. Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes. , 2011, European journal of radiology.
[32] P. Okunieff,et al. Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer , 2011, Radiation oncology.
[33] Matthias Guckenberger,et al. kV Cone-Beam CT-Based IGRT , 2011, Strahlentherapie und Onkologie.
[34] D. Heron,et al. Efficacy and cost-effectiveness analysis of external beam and stereotactic body radiation therapy in the treatment of spine metastases: a matched-pair analysis. , 2011, Journal of neurosurgery. Spine.
[35] P. Weatherall,et al. Phase I Dose-Escalation Study of Stereotactic Body Radiotherapy in Patients With Hepatic Metastases , 2011, Annals of Surgical Oncology.
[36] E. Mendel,et al. Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. , 2011, International journal of radiation oncology, biology, physics.
[37] L. Masi,et al. Efficacy of Eradicative Radiotherapy for Limited Nodal Metastases Detected with Choline PET Scan in Prostate Cancer Patients , 2011, Tumori.
[38] C. Reddy,et al. Recursive partitioning analysis index is predictive for overall survival in patients undergoing spine stereotactic body radiation therapy for spinal metastases. , 2010, International journal of radiation oncology, biology, physics.
[39] L. Constine,et al. Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival. , 2010, International journal of radiation oncology, biology, physics.
[40] B. Kavanagh,et al. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control , 2010, Radiation oncology.
[41] A. Koong,et al. Stereotactic Body Radiotherapy for Colorectal Liver Metastases: A Pooled Analysis , 2010 .
[42] A. Koong,et al. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. , 2010, International journal of radiation oncology, biology, physics.
[43] T. Lacornerie,et al. Stereotactic Radiotherapy of Hepatocellular Carcinoma: Preliminary Results , 2010, Technology in cancer research & treatment.
[44] H. Jang,et al. Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer , 2010, BMC Cancer.
[45] Dong Han Lee,et al. Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma , 2010, Journal of surgical oncology.
[46] E. B. Butler,et al. Stereotactic body radiation therapy (SBRT) for genitourinary malignancies. , 2010, Discovery medicine.
[47] M. Schell,et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. , 2010, Medical physics.
[48] Y. Yamada,et al. Local disease control after decompressive surgery and adjuvant high-dose single-fraction radiosurgery for spine metastases. , 2010, Journal of neurosurgery. Spine.
[49] Lijun Ma,et al. Spinal cord tolerance for stereotactic body radiotherapy. , 2010, International journal of radiation oncology, biology, physics.
[50] M. Gönen,et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. , 2010, Journal of the American College of Surgeons.
[51] R. Jain,et al. Radiosurgical decompression of metastatic epidural compression , 2010, Cancer.
[52] Umberto Ricardi,et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. , 2010, Lung cancer.
[53] Mark K Buyyounouski,et al. Stereotactic body radiotherapy for primary management of early-stage, low- to intermediate-risk prostate cancer: report of the American Society for Therapeutic Radiology and Oncology Emerging Technology Committee. , 2010, International journal of radiation oncology, biology, physics.
[54] S. Perkins,et al. Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma , 2010, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[55] Andrea Bezjak,et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.
[56] P. Levendag,et al. Stereotactic body radiation therapy for colorectal liver metastases , 2010, The British journal of surgery.
[57] Randall K Ten Haken,et al. Guest editor's introduction to QUANTEC: a users guide. , 2010, International journal of radiation oncology, biology, physics.
[58] Ke Sheng,et al. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. , 2010, International journal of radiation oncology, biology, physics.
[59] T. Schultheiss,et al. Radiation dose-volume effects in the spinal cord. , 2010, International journal of radiation oncology, biology, physics.
[60] Peter A S Johnstone,et al. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[61] Lech Papiez,et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. , 2009, International journal of radiation oncology, biology, physics.
[62] M. Bilsky,et al. Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[63] P. Gerszten,et al. Radiotherapy and Radiosurgery for Metastatic Spine Disease: What Are the Options, Indications, and Outcomes? , 2009, Spine.
[64] Fang-Fang Yin,et al. Task Group 142 report: quality assurance of medical accelerators. , 2009, Medical physics.
[65] A. Bezjak,et al. Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer. , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[66] P. Francescon,et al. Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results. , 2009, Anticancer research.
[67] D. Sargent,et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[68] Jan Nyman,et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[69] Colin G Orton,et al. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. , 2009, Medical physics.
[70] Jan Nyman,et al. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[71] A. Muhs,et al. Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy , 2009, Breast Cancer Research and Treatment.
[72] G. Lockwood,et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[73] L. Gaspar,et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[74] Dong Han Lee,et al. Stereotactic Body Radiation Therapy Using Three Fractions for Isolated Lung Recurrence from Colorectal Cancer , 2009, Oncology.
[75] F. Yin,et al. Impact of collimator leaf width and treatment technique on stereotactic radiosurgery and radiotherapy plans for intra- and extracranial lesions , 2009, Radiation oncology.
[76] Kenneth E Rosenzweig,et al. Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk? , 2008, International journal of radiation oncology, biology, physics.
[77] H. Jang,et al. Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis , 2008, BMC Cancer.
[78] Masahiro Hiraoka,et al. Stereotactic body radiotherapy for oligometastatic lung tumors. , 2008, International journal of radiation oncology, biology, physics.
[79] Lawrence B Marks,et al. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. , 2008, Seminars in radiation oncology.
[80] Lech Papiez,et al. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. , 2008, International journal of radiation oncology, biology, physics.
[81] G. Bepler,et al. Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[82] Maria Hawkins,et al. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[83] J. Galvin,et al. Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.
[84] Hiroki Shirato,et al. STEREOTACTIC RADIATION THERAPY WORKSHOP Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study , 2007 .
[85] M. Gonen,et al. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. , 2007, Journal of the American College of Surgeons.
[86] M. Schell,et al. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. , 2007, International journal of radiation oncology, biology, physics.
[87] J. Rock,et al. Partial volume tolerance of the spinal cord and complications of single‐dose radiosurgery , 2007, Cancer.
[88] R. Abrams,et al. Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC). , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[89] Lech Papiez,et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[90] F. Yin,et al. Postoperative Radiosurgery for Malignant Spinal Tumors , 2006, Neurosurgery.
[91] S. Gallinger,et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. , 2006, Journal of the American College of Surgeons.
[92] U. Haedinger,et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases , 2006, Acta oncologica.
[93] Peter C Levendag,et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study , 2006, Acta oncologica.
[94] J. Petersen,et al. Phase II study on stereotactic body radiotherapy of colorectal metastases , 2006, Acta oncologica.
[95] Masahiro Hiraoka,et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. , 2005, International journal of radiation oncology, biology, physics.
[96] P. Gerszten,et al. Single‐fraction radiosurgery for the treatment of spinal breast metastases , 2005, Cancer.
[97] P. Gerszten,et al. Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. , 2005, Journal of neurosurgery. Spine.
[98] J. Petersen,et al. Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer , 2005 .
[99] Sten Nilsson,et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[100] Mohammed Mohiuddin,et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial , 2005, The Lancet.
[101] Z. Fuks,et al. Engaging the vascular component of the tumor response. , 2005, Cancer cell.
[102] John H Suh,et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. , 2005, Journal of the National Cancer Institute.
[103] Maria Werner-Wasik,et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial , 2004, The Lancet.
[104] Y. Takai,et al. Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors. , 2004, International journal of radiation oncology, biology, physics.
[105] D P Berry,et al. The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. , 2003, European journal of cancer.
[106] Jürgen Debus,et al. Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy. , 2002, International journal of radiation oncology, biology, physics.
[107] M. Burt,et al. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. , 1999, Annals of surgery.
[108] G. Tsumatori,et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients , 1998, Cancer.
[109] H. Kogelnik. Inauguration of radiotherapy as a new scientific speciality by Leopold Freund 100 years ago. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[110] B. Nordlinger,et al. Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients , 1996, Cancer.
[111] O. S. Nielsen,et al. Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer‐Soft Tissue and Bone Sarcoma Group study of 255 patients , 1996, Cancer.
[112] M. Burt,et al. Resection of brain metastases from sarcoma , 1995, Annals of Surgical Oncology.
[113] H. Scher,et al. Surgical treatment of spinal cord compression in kidney cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[114] A. Zinsmeister,et al. Pulmonary resection of metastatic renal cell carcinoma. , 1983, Chest.
[115] H. Coutard. PRINCIPLES OF X RAY THERAPY OF MALIGNANT DISEASES , 1934 .
[116] A. Sloan,et al. ACR Appropriateness CriteriaMetastatic Epidural Spinal Cord Compression and Recurrent Spinal Metastasis Expert Panel on Radiation Oncology-Bone Metastases: , 2015 .
[117] H. Lam,et al. Single fraction conventional external beam radiation therapy for bone metastases: a systematic review of randomised controlled trials. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[118] J. Kao,et al. Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases , 2013, Targeted Oncology.
[119] S. Yoo,et al. Preoperative single fraction partial breast radiotherapy for early-stage breast cancer. , 2012, International journal of radiation oncology, biology, physics.
[120] S. Ryu,et al. ACR Appropriateness Criteria® non-spine bone metastases. , 2012, Journal of palliative medicine.
[121] D. Heron,et al. Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive therapeutic strategy. , 2011, Future oncology.
[122] W. Franklin,et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[123] C. Orton,et al. Point/Counterpoint. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. , 2009, Medical physics.
[124] Frcsc Paul D. Greig MD,et al. Survival After Hepatic Resection for Colorectal Metastases: A 10-Year Experience , 2006, Annals of Surgical Oncology.
[125] J. Debus,et al. Stereotactic radiation therapy of liver metastases: update of the initial phase-I/II trial. , 2004, Frontiers of radiation therapy and oncology.
[126] J. Fleshman,et al. Liver resection for colorectal metastases. , 2004, Annals of the Royal College of Surgeons of England.
[127] J. Rock,et al. Patterns of failure after single-dose radiosurgery for spinal metastasis. , 2004, Journal of neurosurgery.
[128] Daniel Normolle,et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. , 2002, International journal of radiation oncology, biology, physics.
[129] I. Lax,et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. , 1995, Acta oncologica.
[130] M. Rotman,et al. Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol. , 1993, International journal of radiation oncology, biology, physics.
[131] S. A. Wilson,et al. Disorders of motility and muscle tone with special reference to the corpus striatum , 1925 .
[132] S. Richardson,et al. Biij Biomedical Imaging and Intervention Journal the Treatment of Primary and Metastatic Renal Cell Carcinoma (rcc) with Image-guided Stereotactic Body Radiation Therapy (sbrt) , 2022 .